Published in Mol Hum Reprod on December 11, 2006
Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts. Am J Physiol Cell Physiol (2010) 1.04
Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion. Reprod Biol Endocrinol (2009) 0.83
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells. Hum Reprod (2008) 0.82
Cell culture models of trophoblast II: trophoblast cell lines--a workshop report. Placenta (2000) 1.70
Is diclofenac helpful in the diagnosis of partial epididymal obstruction? Hum Reprod (1997) 1.38
Metalloproteinases and human placental invasiveness. Placenta (2005) 1.35
Amniotic fluid and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy: comparison with other fetoplacental products. Br J Obstet Gynaecol (1982) 1.20
Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta (2000) 1.19
The rate of development and time of transfer play different roles in influencing the viability of human blastocysts. Hum Reprod (1998) 1.12
Leptin and reproduction. Hum Reprod Update (2000) 1.06
The sex-determining gene tra of Drosophila: molecular cloning and transformation studies. EMBO J (1986) 1.04
Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma. Int J Cancer (1991) 1.04
Radioimmunoassay for the measurement of pregnancy-associated plasma protein-A (PAPP-A) in humans. Biol Reprod (1981) 1.02
Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod (1999) 1.02
Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol Hum Reprod (1999) 1.01
Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod (2000) 1.00
Biochemistry and molecular biology of trophoblast invasion. Ann N Y Acad Sci (2001) 1.00
Can we improve the diagnosis of rupture of membranes? The value of insulin-like growth factor binding protein-1. BJOG (2006) 0.99
Assay of a placental protein to determine fetal risk. Br Med J (1980) 0.97
Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum Reprod (1999) 0.97
CA125 production by the peritoneum: in-vitro and in-vivo studies. Hum Reprod (2000) 0.96
Purification and characterization of pregnancy associated plasma protein A (PAPP-A). Arch Gynecol (1979) 0.96
Studies on pregnancy-associated plasma protein A in the third trimester of pregnancy. Br J Obstet Gynaecol (1979) 0.96
An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med (2001) 0.95
Secretion of matrix metalloproteinases by human endometrial cells in vitro. J Reprod Fertil (1993) 0.95
Serum CA 125 in epithelial ovarian cancer. A longitudinal study. Br J Obstet Gynaecol (1987) 0.92
Measurement of pregnancy associated plasma protein A (PAPP-A). Clin Chim Acta (1979) 0.92
Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells. Endocrinology (1987) 0.91
Human seminal plasma contains a protein that shares physicochemical, immunochemical, and immunosuppressive properties with pregnancy-associated plasma protein-A. J Clin Endocrinol Metab (1983) 0.91
Immunohistochemical localization of pregnancy-associated plasma protein A in decidua and trophoblast: comparison with human chorionic gonadotrophin and fibrin. Placenta (1985) 0.91
Tests of fetal wellbeing in the third trimester of pregnancy. Br J Obstet Gynaecol (1980) 0.89
Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine (2001) 0.88
Modulation of placental vascular endothelial growth factor by leptin and hCG. Mol Hum Reprod (2003) 0.88
Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro. Placenta (1998) 0.87
Relationship of obstetric parameters to the concentration of pregnancy-associated plasma protein A. Am J Obstet Gynecol (1980) 0.87
Pregnancy-associated plasma protein-A (PAPP-A) inhibits thrombin-induced coagulation of plasma. Thromb Res (1983) 0.87
In vitro production of pregnancy-associated plasma protein A by human decidua and trophoblast. Am J Obstet Gynecol (1984) 0.86
Control of MMP-9 expression at the maternal-fetal interface. J Reprod Immunol (2002) 0.86
Mechanisms of endometrial control of trophoblast invasion. J Reprod Fertil Suppl (2000) 0.86
Tissue and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A): comparison with other fetoplacental products. Br J Obstet Gynaecol (1982) 0.86
Serum-dependent effects of IGF-I and insulin on proliferation and invasion of human first trimester trophoblast cell models. Histochem Cell Biol (2002) 0.85
Pregnancy-associated plasma protein-A: an inhibitor of the complement system. Placenta (1981) 0.85
Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol (1981) 0.84
Effects of decidua-conditioned medium and insulin-like growth factor binding protein-1 on trophoblastic matrix metalloproteinases and their inhibitors. Placenta (1998) 0.84
Are vaginal fluid concentrations of prolactin, alpha-fetoprotein and human placental lactogen useful for diagnosing ruptured membranes? Br J Obstet Gynaecol (1983) 0.83
GRP78 as a marker of pre-eclampsia: an exploratory study. Mol Hum Reprod (2009) 0.83
Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies. Cancer Res (2000) 0.82
Longitudinal study of CEA and CA125 in ovarian cancer. Gynecol Oncol (1985) 0.82
Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome. Br J Cancer (2012) 0.82
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells. Hum Reprod (2008) 0.82
Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol (1995) 0.82
Is cellular fibronectin a biological marker for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol (2001) 0.81
Repression of the putative tumor suppressor gene Bard1 or expression of Notch4(int-3) oncogene subvert the morphogenetic properties of mammary epithelial cells. Adv Exp Med Biol (2000) 0.81
Comparison of the effects of GnRH-I and GnRH-II on HCG synthesis and secretion by first trimester trophoblast. Mol Hum Reprod (2001) 0.81
Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin (hCG). Eur J Obstet Gynecol Reprod Biol (2003) 0.81
Pregnancy-associated plasma protein A (PAPP-A) specifically inhibits the third component of human complement (C3). Placenta (1984) 0.81
Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). Hum Reprod (1994) 0.81
Cancer antigen 125 is produced by human endometrial stromal cells. Hum Reprod (1986) 0.81
Histochemical localization of pregnancy-associated plasma protein A in fetal, infant, and adult organs and comparison between antisera. Gynecol Obstet Invest (1984) 0.80
Evaluation of infertility. Hum Reprod Update (1995) 0.80
The disappearance rate of pregnancy-associated plasma protein-A (PAPP-A) after the end of normal and abnormal pregnancies. Arch Gynecol (1984) 0.80
Endometrial and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A). Br J Obstet Gynaecol (1982) 0.80
Gelatinase and oncofetal fibronectin secretion is dependent on integrin expression on human cytotrophoblasts. Hum Reprod (1995) 0.80
Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy. Br J Obstet Gynaecol (1986) 0.80
Pregnancy-associated plasma protein-A (PAPP-A): concentration in uterine fluid and immunohistochemical localization in the endometrium. Br J Obstet Gynaecol (1984) 0.79
Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta. Int J Gynecol Cancer (2006) 0.79
Expression of pro-EPIL peptides encoded by the insulin-like 4 (INSL4) gene in chromosomally abnormal pregnancies. J Clin Endocrinol Metab (2000) 0.79
Long-term results of GnRH analogue (Buserelin) treatment in girls with central precocious puberty. Acta Paediatr Scand (1985) 0.79
Circulating levels of pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotrophin (hCG) in intrauterine and extrauterine pregnancies. Br J Obstet Gynaecol (1983) 0.79
IFPA meeting 2008 workshops report. Placenta (2008) 0.79
Trophoblastic p53 is stabilised by a cis-trans isomerisation necessary for the formation of high molecular weight complexes involving the N-terminus of p53. Biochimie (2008) 0.79
Involvement of trophoblast in embryo implantation: regulation by paracrine factors. J Reprod Immunol (1998) 0.79
Expression of stromelysin-3 in the human placenta and placental bed. Placenta (1997) 0.79
Distribution of type-I interferon-receptors in human first trimester and term placental tissues and on isolated trophoblast cells. Am J Reprod Immunol (1997) 0.78
Is pregnancy-associated plasma protein A (PAPP-A) an immunomodulator during human pregnancy? Placenta Suppl (1982) 0.78
Immunoregulatory activity in supernatants from cultures of normal human trophoblast cells of the first trimester. Am J Obstet Gynecol (1989) 0.78
Increased follicle stimulating hormone in infertile men. Is increased plasma FSH always due to damaged germinal epithelium? Hum Reprod (1995) 0.78
Modulation of human cytotrophoblastic leptin secretion by interleukin-1alpha and 17beta-oestradiol and its effect on HCG secretion. Mol Hum Reprod (1999) 0.78
[Amiodarone and the thyroid gland]. Schweiz Med Wochenschr (1981) 0.78
The presence of pregnancy-associated plasma protein-A in human corpora lutea: cellular and subcellular distribution and dependence on reproductive state. Biol Reprod (1991) 0.78
From basic research to clinical application of placental proteins--a workshop report. Placenta (2004) 0.77
Effects of human chorionic gonadotropin on trophoblast invasion. Semin Reprod Med (2001) 0.77
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation. Int J Cancer (1995) 0.77
Telomere length, comorbidity, functional, nutritional and cognitive status as predictors of 5 years post hospital discharge survival in the oldest old. J Nutr Health Aging (2012) 0.77
CA 125 is an excretory product of human endometrial glands. Biol Reprod (1990) 0.76
Elucidation of the mechanism responsible for the luteolytic effect of oestradiol during pseudogestation in the rat. Experientia (1974) 0.76
Modulation of human chorionic gonadotrophin bioactivity during the first trimester of pregnancy. Hum Reprod (1998) 0.76
[Prediction of prematurity by oncofetal fibronectin. Prospective cohort study]. J Gynecol Obstet Biol Reprod (Paris) (1995) 0.76
Identification and partial purification of calmodulin-binding microtubule-associated proteins from Neurospora crassa. Eur J Biochem (1994) 0.76
Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen. Arch Gynecol (1985) 0.76
Extracellular matrix influences hormone and protein production by human chorionic villi. Cell Tissue Res (1990) 0.75
Binding of pregnancy-associated plasma protein-A (PAPP-A) to placental subfractions. Arch Gynecol (1986) 0.75
In vitro production of pregnancy-associated plasma protein-A (PAPP-A) by trophoblastic cells. Arch Gynecol (1986) 0.75
Progesterone dependence and extratrophoblastic origin of pregnancy-associated plasma protein-A (PAPP-A) in early pregnancy. Arch Gynecol (1986) 0.75